Beneficiaries with questions about the Medicare GLP-1 Bridge program can also call 1-800-MEDICARE (TTY: 1-877-486-2048)
It does not contain finasteride or another pharmaceutical DHT-blocking drug
Although GLP-1RAs have revolutionized metabolic disease management, their potential therapeutic role in ocular diseasesparticularly those driven by shared metabolic and inflammatory pathwaysremains underexplored, despite growing preclinical evidence
Macular Degeneration In June 2025, a large study of older adults with Type 2 diabetes found those who took a GLP-1 drug had a "substantially higher risk" of developing a rare type of age-related macular degeneration an eye disease that causes blindness than people with diabetes who didn't take the medication
These receptors are widely distributed throughout the central nervous system and peripheral tissues, mediating diverse physiological functions including pigmentation, energy homeostasis, sexual function, inflammation, and cardiovascular regulation
Why Choose mctlaw to Represent You in a Trulicity Lawsuit We put our clients first
